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OBJECTIVE—We examined the effect of -adrenergic receptor
(AR) activation and cAMP-elevating agents on respiration and
mitochondrial uncoupling in human adipocytes and probed the
underlying molecular mechanisms.
RESEARCH DESIGN AND METHODS—Oxygen consumption
rate (OCR, aerobic respiration) and extracellular acidiﬁcation
rate (ECAR, anaerobic respiration) were examined in response
to isoproterenol (ISO), forskolin (FSK), and dibutyryl-cAMP
(DB), coupled with measurements of mitochondrial depolariza-
tion, lipolysis, kinase activities, and gene targeting or knock-
down approaches.
RESULTS—ISO, FSK, or DB rapidly increased oxidative and
glycolytic respiration together with mitochondrial depolarization
in human and mouse white adipocytes. The increase in OCR was
oligomycin-insensitive and contingent on cAMP-dependent pro-
tein kinase A (PKA)-induced lipolysis. This increased respiration
and the uncoupling were blocked by inhibiting the mitochondrial
permeability transition pore (PTP) and its regulator, BAX. Inter-
estingly, compared with lean individuals, adipocytes from obese
subjects exhibited reduced OCR and uncoupling capacity in
response to ISO.
CONCLUSIONS—Lipolysis stimulated by AR activation or
other maneuvers that increase cAMP levels in white adipocytes
acutely induces mitochondrial uncoupling and cellular energet-
ics, which are ampliﬁed in the absence of scavenging BSA. The
increase in OCR is dependent on PKA-induced lipolysis and is
mediated by the PTP and BAX. Because this effect is reduced
with obesity, further exploration of this uncoupling mechanism
will be needed to determine its cause and consequences.
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A
dipose tissue is a key component in the man-
agement of whole-body energy balance and
metabolic homeostasis. In mammals, adipose
tissue is composed of white and brown adipose
tissue (WAT, BAT). Both tissues are similar in that they
are highly responsive to insulin to store energy as triglyc-
eride, and both respond to catecholamines to catabolize
these energy reserves into their constituent fatty acids
(FAs) and glycerol. However, the fate of released FAs from
BAT and WAT is different. Brown adipocytes possess a
rich complement of mitochondria and are the only cell
type to express uncoupling protein (UCP1). After cate-
cholamine stimulation of the -adrenergic receptors
(ARs), UCP1 activation (by the released FAs) increases
the proton conductance of the inner mitochondrial mem-
brane (IMM) and dissipates the electrochemical proton
gradient that is the driving force for ATP synthesis in a
process termed “mitochondrial uncoupling” (rev. in 1,2).
Catecholamine stimulation also increases Ucp1 gene ex-
pression and mitochondrial mass, altogether resulting in
robust oxidation of FAs for heat production and energy
expenditure. White adipocytes have fewer mitochondria
and negligible amounts of UCP1. Upon AR stimulation of
WAT, FAs liberated by lipolysis are mostly released into
the circulation. Although an important source of energy
for other tissues, chronically elevated circulating FAs in
obesity are associated with insulin resistance and progres-
sion to type 2 diabetes (3).
Because of recent evidence for the existence of BAT in
adult humans (rev. in 4), (5–9) there is renewed interest in
the idea that mitochondrial uncoupling could contribute to
FA oxidation and weight reduction. However, it is not yet
clear whether there are sufﬁcient numbers of brown
adipocytes to have a signiﬁcant impact on body weight and
energy expenditure, and most of the adipose tissue in
adult humans consists of white adipocytes. More recently,
white adipocytes are appreciated to have a greater com-
plement of mitochondria than previously thought (10), and
there are recent reports showing that FAs in adipocytes
can be oxidized in situ (11–13). Earlier suggestions in the
literature also noted that rodent white adipocytes can
exhibit mitochondrial uncoupling after catecholamine
stimulation (14,15). Also of note, previous experiments in
mice with ectopic expression of UCP1 in WAT from the
adipocyte FA–binding protein (aP2) promoter docu-
mented the potential of mitochondrial uncoupling in vivo
and resistance to dietary obesity (16). The uncoupling role
of FAs released during white adipocyte lipolysis and its
molecular basis remain unclear, especially in less com-
monly studied human adipocytes. Therefore, a better
understanding of the potential role for white adipocytes to
engage in metabolic fuel oxidation and uncoupling is
warranted.
Using an approach combining measures of oxygen con-
sumption rate (OCR, aerobic respiration), extracellular
acidiﬁcation rate (ECAR, anaerobic respiration or glycol-
ysis), mitochondrial inner membrane potential, and bio-
chemical measurements, we present evidence that human
white adipocytes can acutely increase aerobic and anaer-
obic respiration in response to AR and protein kinase A
(PKA)-dependent stimulation of lipolysis. Under condi-
tions where the released FAs are not scavenged by BSA in
the medium, we show that the increase in respiration
results, in part, from mitochondrial uncoupling. Moreover,
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ating this uncoupling involves the mitochondrial perme-
ability transition pore (PTP) and its regulator protein BAX.
Interestingly, this AR-stimulated respiration is reduced
with obesity. Such compromised capacity could contrib-
ute to increased adipocyte size, elevated plasma FA levels
and oxidative stress—all of which exist in obesity and its
metabolic complications.
RESEARCH DESIGN AND METHODS
Materials included forskolin (FSK), isoproterenol (ISO), dibutyryl-cAMP
(DB), N-[2-(p-bromocinnamylamino)-ethyl]-5-isoquinoline-sulfonamide (H89),
GlutaMAX, gelatin, carbonylcyanide-p-triﬂuoromethoxyphenyl-hydrazone
(FCCP), cyclosporin-A (CSA), rotenone, and FA-free BSA (Sigma-Aldrich, St.
Louis, MO), oligomycin (Oligo) (Calbiochem, San Diego, CA), the cAMP
antagonist Rp-cAMPS (Enzo Life Sciences, Farmingdale, NY), tetramethylrho-
damine methyl ester (TMRM), and MitoTracker Green (MTG) (Molecular
Probes; Invitrogen, San Diego, CA).
Cell cultures. Human preadipocytes (Zen-Bio, Research Triangle Park, NC)
were isolated from human subcutaneous adipose tissue using conventional
techniques including enzymatic dissociation, differential centrifugation, and
plating. Cells were seeded into 0.2% gelatin-covered 24-well XF24 plates
(#100777-004; 13,000 cells/well) (Seahorse Bioscience, North Billerica, MA) for
OCR and ECAR experiments, 60-mm dishes (8  10
5 cells) for confocal
microscopy, and 6-well plates (4  10
5 cells/well) for Western blotting.
Growth for 24–48 h in preadipocyte media (PM-1; Zen-Bio) contained
Dulbecco’s modiﬁed Eagle’s medium F12 (DMEM/F12 [1:1, v/v]), HEPES (pH
7.4), 10% FBS, and antibiotics. Cells were differentiated for 7 days in media
containing DMEM/F12 (1:1; v/v), HEPES (pH 7.4), 10% FBS, biotin, pantothe-
nate, insulin, dexamethasone, isobutylmethylxanthine (IBMX), and a nonthia-
zolidinedione peroxisome proliferator–activated receptor (PPAR)- agonist
(DM-2; Zen-Bio), followed by an additional week in adipocyte maintenance
media (DM-2 without IBMX and PPAR agonist [AM-1, Zen-Bio]).
Mouse adipocytes, 3T3-L1 and 3T3-F442A cells, were grown and differen-
tiated as described (17) for up to 10 days. Twenty-four h before XF24 analysis,
cells were trypsinized and seeded at 25,000 cells/well in the plates.
Animals. Age-matched male Ucp2
/ and Ucp2
/ mice (10–16 weeks old)
on a C57BL/6J background were created in our lab as described previously
(18,19). Animals were housed and genotyped as previously described (19) and
fed standard rodent chow. All protocols for animal use were approved by the
Institutional Animal Care and Use Committee of The Hamner Institutes in
accordance with National Institutes of Health guidelines.
Cellular metabolic rate. Human or mouse adipocytes were washed with 1
ml XF-DMEM (#D5030, Sigma-Aldrich) containing sodium pyruvate (1 mmol/
l), GlutaMAX-1 (2 mmol/l), glucose (17.5 mmol/l), NaCl (1.85 g/l), phenol red
(15 mg/l, pH 7.4), and 500 l were added per well. Cellular OCR and ECAR
were measured (model XF24, Seahorse Bioscience) as described previously
(20). Per speciﬁc experiments, drugs were delivered to ﬁnal concentrations of
ISO (1 mol/l), FSK (10 mol/l), Oligo (1 g/ml), FCCP (0.6 mol/l), and
rotenone (3 mol/l). For some experiments, cells were pretreated with H89
(10 mol/l), DB (1 mmol/l), Rp-cAMPS (0.5 mmol/l), 5% FA-free BSA or CSA
(5 g/ml). Optimal drug concentrations were determined in preliminary
experiments.
Tissues. Freshly isolated mouse gonadal WAT was rinsed with XF-DMEM
containing 25 mmol/l HEPES, cleaned of nonadipose material and cut into
pieces (10 mg). After extensive washing, one piece of tissue was placed in
each well of a XF24-well plate (#101122-100, Seahorse Bioscience) and
covered with a customized screen that allows free perfusion while minimizing
tissue movement. XF-DMEM (500 l) was added per well, and samples were
analyzed in the XF24.
Mitochondrial membrane potential and mitochondrial mass by confocal
microscopy. Differentiated human or mouse 3T3-L1 adipocytes were
trypsinized and seeded onto 0.2% gelatin coated glass-bottom 10-mm culture
dishes (MatTak Corporation, Ashland, MA). After overnight incubation at
37°C, 5% CO2, cells were either treated with ISO (1 mol/l, 30 min) or FSK (10
mol/l, 60 min) and subsequently stained with 20 nmol/l TMRM or with 15
nmol/l MTG (45 min at 37°C, in the dark). Cells were washed twice with 1 ml
phenol red-free DMEM (#31053; GIBCO) and visualized by laser scanning
confocal microscopy (Zeiss, Thornwood, NY). FCCP (40 mol/l, 60 min) was
used as a control for mitochondrial uncoupling and depolarization. Fluores-
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FIG. 1. Elevated cAMP levels acutely induce respiration in white adipocytes. Representative measurements of the percent increase in OCR (A)
or ECAR (C), respectively, relative to baseline rates in response to ISO, FSK, or DB in human adipocytes. As indicated, at 0 min ISO (1 mol/l),
FSK (10 mol/l), DB (1 mmol/l), or DMEM (CONT) were injected. OCR (A) or ECAR (C) measurements before drug injection were set as 100%.
Adipocytes were pooled from ﬁve different human subjects, and each data point is a mean of 4–6 wells. Histograms summarizing the average
maximal percent increase of OCR (B) or ECAR (D), respectively, over their baseline rates in response to ISO, FSK, DB, and FCCP (0.6 mol/l).
Data are collected from 8 to 10 experiments, using a total of 20 subjects (BMI 21.7–35.5 kg/m
2). All experiments included wells that received ISO,
FSK, or DB and wells that received FCCP. *P < 0.001; #P < 0.01 compared with CONT.
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netics, Bethesda, MD).
Lipolysis and PKA activity. Glycerol release and PKA activity in differenti-
ated human adipocytes were measured as described (21) after ISO treatment
(1 mol/l, 2 h for lipolysis; 15 min for PKA activity).
Small interfering RNA. Differentiated human adipocytes were transfected
with small interfering RNAs (siRNAs) using INTERFERin reagent (Polyplus-
transfection; Genesee Scientiﬁc, San Diego, CA) per the manufacturer for 24
or 48 h as detailed in Fig. 8 and in supplementary Fig. 6 in the online appendix
available at http://diabetes.diabetesjournals.org/cgi/content/full/db10-0245/
DC1. Total cellular RNA was extracted for real-time PCR (RT-PCR), or
respiration measurements were performed in the XF24. Optimal transfection
conditions were determined in preliminary experiments for each gene target,
which also included siRNA positive control (Hs_MAPK1, Qiagen).
RNA extraction and RT-PCR. Total RNA was isolated using TRIzol in
combination with PureLink Micro-to-Midi Total RNA Puriﬁcation System
(Invitrogen). Reverse transcription was performed using High-Capacity cDNA
Kit with random primers on a Veriti 96-well Thermal Cycler (Applied Biosys-
tems). RT-PCR was done using TaqMan or SYBR Green (Applied Biosystems)
in an ABI PRISM 7900HT Sequence Detection System. RT-PCR primers are
described in supplementary Fig. 6. All data were normalized to g lyceralde-
hyde - 3-phosphate dehydrogenas (GAPDH) content.
Western blotting. Cells were lysed and protein concentrations measured by
BCA (Pierce); 2.5 g of each sample was fractionated by electrophoresis for
Western blotting, all exactly as described previously (21). Primary and
secondary antibodies were obtained from Cell Signaling Technology (Dan-
vers, MA) or Santa Cruz Biotechnology (Santa Cruz, CA).
Data analysis. Statistical analysis was performed by one-way repeated-
measures ANOVA with Newman-Keuls post hoc test. For comparison of two
groups, signiﬁcance was analyzed by Student t test. Results are represented as
means  SE, unless otherwise noted in the ﬁgure legends.
RESULTS
Elevated cAMP levels acutely induce respiration in
white adipocytes. Continuous measurements of OCR and
ECAR were collected from human adipocytes over time.
The addition of ISO, FSK, or DB led to a rapid increase in
OCR, which gradually peaked after 20–30 min (ISO) or 60
min (FSK, DB) and then slowly declined (Fig. 1A). Figure
1B presents the average maximal OCR changes from
several experiments, with maximal rates of respiration
measured by the mitochondrial uncoupler FCCP. Similar
increases in OCR in response to elevations in cAMP were
also observed in mouse WAT (supplementary Fig. 1A) and
cell lines (supplementary Figs. 1B and 2A). Note from a
technical standpoint that the same responses and kinetics
are observed for freshly isolated adipose tissue, adipo-
cytes, or cell lines, although the response in the cell lines
was weaker.
The increase in ECAR was more rapid than for OCR,
reaching a peak after 10 min and then declining (Fig. 1C).
This rise in ECAR was fully inhibited by the lactate
dehydrogenase inhibitor, oxamate (5 mmol/l, not shown),
indicating an acute increase in glycolysis (20). The maxi-
mum percent change in ECAR is summarized in Fig. 1D.
ECAR was also increased in 3T3-L1 and 3T3-F44A adipo-
cytes in response to ISO or FSK (supplementary Figs. 1C
and 2B).
cAMP-induced mitochondrial uncoupling. We next de-
termined whether mitochondrial uncoupling was a con-
tributor to the increased OCR in response to cAMP-
elevating agents by using the ATP synthase inhibitor Oligo
and by examining cells stained with the ﬂuorescent dye
TMRM, which accumulates speciﬁcally in the mitochon-
drial matrix as a function of IMM potential. As shown in
Fig. 2A–D, under basal conditions Oligo inhibited OCR by
50–60%. However, in ISO-, FSK-, or DB-treated cells, OCR
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FIG. 2. Elevated cAMP levels induce Oligo-insensitive OCR. Representative measurements of the percent change in OCR in human adipocytes
after injections of DMEM (open symbols) or the inhibitors (closed symbols) ATP synthase inhibitor oligomycin (Oligo (1 g/ml) or the complex
1 inhibitor rotenone (3 mol/l), as indicated by the dashed vertical lines. Oligo was injected 30–40 min after ISO (1 mol/l) (A), FSK (10 mol/l)
(B), DB (1 mmol/l) (C), or DMEM (CONT). OCR before Oligo injection was set as 100%. The results are from adipocytes pooled from ﬁve subjects,
and each data point is a mean of 4–5 wells. D: Histogram summarizing the percent decrease in OCR in response to Oligo or rotenone injections.
Data are relative to OCR levels before Oligo injection (and after ISO, FSK, or DB injections). The data are an average of 3–5 experiments using
a total of 15 subjects (BMI 21.7–35.5 kg/m
2). *P < 0.001, compared with untreated CONT;
∧P < 0.01, compared with untreated ISO; #P < 0.001,
compared with CONT  Oligo. E: The relative changes in OCR between Oligo and rotenone are expressed as % uncoupling (calculated from the
results presented in D, dotted arrows). Rot, rotenone.
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ﬁnding suggests that some of the cAMP-induced OCR is
uncoupled respiration. To further assess percent of uncou-
pling, cells were treated with rotenone, which inhibits
respiratory chain activity at Complex I, with the remaining
OCR from nonmitochondrial sources. Figure 2D shows
that about 20% of total OCR remains in the presence of
rotenone and is similar for all groups. After accounting for
this nonmitochondrial OCR (shown by the dotted arrows
in Fig. 2D and illustrated as percent uncoupling in Fig. 2E),
mitochondrial uncoupling accounts for 30% of OCR in
untreated control cells, 55% of ISO-induced respiration
and 65–70% of FSK- or DB-stimulated respiration. We next
analyzed TMRM ﬂuorescence intensity by confocal mi-
croscopy. Figure 3 shows that TMRM intensity is signiﬁ-
cantly reduced in either ISO- or FSK-treated human
adipocytes relative to untreated control cells. Note that
the changes in TMRM intensity occur speciﬁcally in the
differentiated adipocytes, recognized by their lipid accu-
mulation (arrows in Fig. 3A) and occur in the presence of
serum-containing media. The changes in ﬂuorescence in-
tensity are summarized in Fig. 3B. Both ISO and FSK
decreased IMM potential by about 50%. Similar results
were obtained in mouse 3T3-L1 adipocytes (supplemen-
tary Fig. 3). All together, these results indicate that AR
stimulation or cAMP-elevating agents can acutely increase
mitochondrial uncoupling in white adipocytes.
cAMP-induced OCR is FA-dependent. In adipocytes,
AR agonists stimulate lipolysis to generate FFAs. This
response depends largely on the activation of PKA (17).
We examined the involvement of PKA as well as the
liberated FAs on cAMP-induced changes in adipocyte
respiration. We used two mechanistically different inhibi-
tors of PKA: the catalytic inhibitor H89 (22) and the
competitive cAMP antagonist Rp-cAMPS (23). Figure 4A
and B shows that both H89 and Rp-cAMPS inhibited ISO-
or FSK-induced OCR. Both inhibitors also effectively
blocked the increase in ECAR (Fig. 4C; average of several
experiments presented in Fig. 4D). To examine the role of
the liberated FAs on respiration, cells were provided with
5% BSA (FA-free) prior to ISO or FSK injections (15). A
sample dataset of OCR is shown in Fig. 5A, and results
from several experiments are summarized in Fig. 5B. The
increase in OCR induced by either ISO or FSK was
signiﬁcantly reduced due to scavenging by BSA of the FAs
released from lipolysis. Similar results were obtained in
mouse 3T3-F442A adipocytes (supplementary Fig. 2A).
Together, the data suggest that the FAs released by
PKA-dependent lipolysis contribute to the cAMP-depen-
dent mitochondrial oxidative respiration of white adipo-
cytes, consistent with other studies (15,24). Although
these data do not clearly distinguish between FAs as a
substrate, uncoupler, or both, two additional observations
suggest that FAs contribute to both. First, in contrast to
OCR, ECAR levels in the presence of BSA were even
higher after ISO or FSK (Fig. 5C and D; supplementary Fig.
2B). This suggests that the reduction of available FAs from
lipolysis for oxidation resulted in increased glycolysis. The
cells respire well on other substrates (e.g., pyruvate)
because they increase respiration in response to FCCP and
in the absence of cAMP elevation. Second, a much earlier
study in primary rat adipocytes reported that mitochon-
drial depolarization observed after ISO treatment was
largely prevented by pretreatment with FA-free BSA (15).
Also, the reduction in mitochondrial membrane potential
measured by confocal microscopy was performed in the
presence of complete serum-containing media.
To further evaluate the importance of lipolysis in this
cAMP-induced respiration, we used a siRNA approach to
suppress the expression of the important lipase, adipose
triglyceride lipase (ATGL) (25). Knock-down of ATGL
(supplementary Fig. 5B) resulted in a dramatic inhibition
of FSK-induced OCR (Fig. 6A and B). The portion of OCR
that was not inhibited may be due to residual ATGL.
FSK-induced ECAR was not changed with ATGL knock-
down (Fig. 6C and D). These data support the role of
lipolysis in the cAMP-induced oxidative respiration in
white adipocytes.
cAMP-induced OCR is reduced with obesity. Catechol-
amine responsiveness of adipose tissue to increase lipol-
ysis has been reported to become impaired with increasing
BMI (rev. in 26,27). Therefore, an interesting question is
whether adipocytes of obese individuals have an equiva-
lent capacity for this AR-activated increase in cAMP-
dependent respiration. We compared ISO-induced OCR
and ECAR in adipocytes from lean (BMI 21.7–24.6 kg/m
2)
or obese (BMI 30–35.5 kg/m
2) donors. As seen in Fig. 7, the
increase in OCR by ISO was impaired in adipocytes from
obese subjects (Fig. 7A and B). ECAR was not changed
(Fig. 7C and D). This deﬁcit in OCR response from obese
CONT
ISO
FSK
FCCP 0.00
0.25
0.50
0.75
1.00
* *
*
T
M
R
M
f
l
u
o
r
e
s
c
e
n
c
e
i
n
t
e
n
s
i
t
y
 
(
f
o
l
d
)
Ph-Cont
CONT
ISO
FSK
Ph-Cont TMRM
40X objective 
A
B
TMRM
FIG. 3. Elevated cAMP levels induce mitochondrial depolarization. A:
Microscopy images of human adipocytes stained with TMRM and visual-
ized under confocal microscopy or their phase-contrast (Ph-Cont) mode.
Cells were treated with ISO (1 mol/l, 30 min) or FSK (10 mol/l, 60 min)
in DMEM  10% FBS, stained with TMRM and immediately analyzed, as
described in RESEARCH DESIGN AND METHODS. The scale bar in the images
represents 20 microns. B: Histogram summarizing TMRM ﬂuorescence
intensity of untreated (CONT) and ISO-, FSK-, or FCCP- (40 mol/l, 60
min) treated cells of 50 images collected from three independent exper-
iments. TMRM intensity in the untreated cells (CONT) was set as 1. *P <
0.001, compared with CONT. (A high-quality digital representation of this
ﬁgure is available in the online issue.)
E. YEHUDA-SHNAIDMAN AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 59, OCTOBER 2010 24770%
50%
100%
150%
200%
250%
ISO
-  -  +
CONT H89 Rp-cAMPS
FSK
-  +  -
-  -  +
-  +  -
-  -  +
-  +  -
*
^ ^ # #
*
M
a
x
i
m
u
m
 
%
 
i
n
c
r
e
a
s
e
o
v
e
r
 
b
a
s
e
l
i
n
e
 
O
C
R
0%
50%
100%
150%
200%
CONT
ISO+H89
Time (min)
0 7
CONT+H89
FSK
14 21 28 35 42 49 56
FSK+H89
ISO
%
 
o
f
 
b
a
s
e
l
i
n
e
E
C
A
R
0%
100%
200%
300%
CONT
ISO
ISO+H89
Time (min)
0 7
CONT+H89
FSK
FSK+H89
14 21 28 35 42 49 56
%
 
o
f
 
b
a
s
e
l
i
n
e
O
C
R
0%
100%
200%
300%
ISO
-  -  +
CONT H89 Rp-cAMPS
FSK
-  +  -
-  -  +
-  +  -
-  -  +
-  +  -
*
^ ^ # #
*
M
a
x
i
m
u
m
 
%
 
i
n
c
r
e
a
s
e
o
v
e
r
 
b
a
s
e
l
i
n
e
 
E
C
A
R D B
C A
FIG. 4. cAMP-induced respiration is PKA-dependent. Representative measurements of the percent increase in OCR (A) and ECAR (C), relative to
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FIG. 5. cAMP-induced OCR is FA-dependent. Representative measurements of the percent increase in OCR (A) and ECAR (C), relative to baseline
rates, in response to ISO or FSK in adipocytes in the presence or absence of FA-free BSA. At 0 min, ISO (1 mol/l), FSK (10 mol/l), or DMEM
(CONT) was injected to cells that were pretreated (closed symbols) or not (open symbols) with BSA (5%, 1 h). Each data point is the mean of
four wells, and error bars not visible are contained within the symbols. Histograms summarizing the maximum percent increase of OCR (B)o r
ECAR (D) in response to DMEM (CONT), ISO, FSK or DB (1 mmol/l) over their baseline rates. Data are an average of 11 subjects (BMI 21.7–35.5
kg/m
2), measured in three independent experiments. *P < 0.05, compared with CONT; #P < 0.05, compared with respective samples without BSA.
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adipocytes, as measured by Nile Red staining and the
expression of such differentiation markers as aP2, CCAAT/
enhancer-binding protein (C/EBP)-	, PPAR coactivator
(PGC)-1	, PPAR2, and hormone-sensitive lipase (not
shown). There were also no discernible differences in
mitochondrial mass, as measured by MTG (supplementary
Fig. 4A) or by gene expression of mitochondrial proteins
(cytochrome C, ATP synthase, and cytochrome C oxidase
subunits [not shown]). Moreover, other parameters that
were not different between lean and obese included ISO-
stimulated lipolysis (supplementary Fig. 4B) or PKA activ-
ity (supplementary Fig. 4C), basal OCR (supplementary
Fig. 4D), and AR subtype expression (not shown). Inter-
estingly, maximal OCR evoked by FCCP (supplementary
Fig. 4E) was also signiﬁcantly reduced in adipocytes from
obese subjects, while basal respiration was less sensitive
to Oligo (supplementary Fig. 4F).
cAMP-induced mitochondrial uncoupling is mediated
by BAX and the PTP. A number of mitochondrial pro-
teins have been associated with uncoupling induced by
FAs (rev. in 2,28). These include members of the mito-
chondrial carrier family such as UCP1, the adenine nucle-
otide translocases (ANTs), phosphate carrier (PiC),
aspartate/glutamate carrier (AGC), and the PTP complex.
The subunit composition of the PTP is not completely
clear (28,29). It is thought to consist of the integral
membrane proteins ANT and voltage-dependent anion
channel 1 (VDAC1) and regulatory proteins of the BCL-2
family, which control the open-closed states of the pore
(29,30).
We assessed the involvement, if any, of major proteins
in these groups in WAT that could be candidates for
mediating this cAMP-triggered respiration in white adipo-
cytes. First, we measured their expression levels in human
white adipocytes by RT-PCR. Expression of ANT3, PiC,
UCP2, VDAC1, BAX, and to a lesser extent ANT2/1 is
relatively abundant in white adipocytes, whereas that of
UCP1, UCP5, ANT4, and AGC is very low (supplementary
Fig. 5A). Therefore, we focused on the former group,
measuring the OCR response to ISO after targeted reduc-
tion of these candidates. The involvement of UCP2 was
assessed using WAT from Ucp2
/ and Ucp2
/ mice
(18,19), and the increase in OCR was identical between the
two genotypes (supplementary Fig. 5C). Expression of
ANT3, ANT2, PiC, VDAC1, or BAX in human adipocytes
was suppressed by siRNAs. The efﬁciency of targeted
knock-down was 75–85% versus the scrambled siRNA
(supplementary Fig. 5B). The OCR response was un-
changed in cells receiving the siRNAs for PiC, ANT3,
ANT2, ANT2ANT3, or VDAC1 (supplementary Fig. 5C).
However, knock-down of BAX, as shown in Fig. 8A and B,
resulted in a signiﬁcant decrease in the OCR response to
ISO (Fig. 8C and D). Because BAX can increase mitochon-
drial uncoupling by opening the PTP (30), we also treated
cells with the speciﬁc PTP inhibitor CSA (29) prior to
measuring cAMP-induced OCR. Figure 8E and F shows
that CSA similarly inhibited the OCR response to either
ISO or FSK. Together these results suggest an important
role for BAX to regulate PTP opening for this cAMP and
FA-induced mitochondrial uncoupling in white adipocytes.
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FIG. 6. cAMP-induced OCR is dependent upon ATGL. Human adipocytes were transfected with siRNA targeted to ATGL or scrambled sequence
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0.05, compared with FSK  SCR.
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The ability of adipocytes to oxidize FAs and uncouple
mitochondrial respiration in response to AR activation is
best understood in brown adipocytes, where the high
density of mitochondria and the presence of the unique
protein UCP1 allow for robust OCR and energy expendi-
ture. Obviously, white adipocytes have less oxidative
capacity than brown adipocytes, and their ability to oxi-
dize FA is much lower (24,31). Nevertheless, a case can be
made for assessing the relevance of WAT as a target for
increasing energy expenditure based on the sheer amount
of the tissue as a percentage of body mass. In fact,
evidence exists in rodent adipocytes for a moderate in-
crease in FA oxidation in response to AR activation
(12,24), and various futile cycles have been examined in
adipocytes (32).
Several years ago, a collection of unrelated reports
suggested that epinephrine could increase OCR in rat
epididymal fat pads ([33] and references therein) or pri-
mary cultures of rat adipocytes (14). AR-stimulated lipol-
ysis in these adipocytes was also associated with both
FA-dependent IMM depolarization (15,34) and a decrease
in ATP levels (14,15,34,35). A more direct link between
lipolysis and ATP levels was shown in 3T3-L1 cells in
which the generic lipase inhibitor orlistat suppressed
FSK-stimulated lipolysis as well as the drop in ATP con-
tent (36). Because a high OCR together with mitochondrial
depolarization and ATP reduction are common character-
istics of mitochondrial uncoupling, all together these stud-
ies suggest there is mitochondrial uncoupling in response
to AR activation. However, no single study has presented
cohesive evidence for AR-induced uncoupling in white
adipocytes, especially in human adipocytes, and a molec-
ular mechanism was not identiﬁed.
Here, we ﬁnd an acute increase in the cellular energetics
of human white adipocytes in response to AR activation
or cAMP-elevating agents that is dependent on the FAs
liberated by lipolysis. In following cAMP-induced changes
in cellular respiration over time, the increases in both
aerobic (measured as OCR) and anaerobic (measured as
ECAR) respiration were immediate and transient. The
ECAR response was faster than OCR, implying that glu-
cose oxidation preceded FA oxidation. Importantly, a
major portion of cAMP-induced OCR was Oligo-insensi-
tive, implying that some respiration was independent
of ATP synthase activity. These results, together with
mitochondrial depolarization, represent mitochondrial
uncoupling.
The physiological signiﬁcance of mitochondrial uncou-
pling in white fat is not fully understood and is debated
(13,31,37) (rev. in 38). One consequence of mitochondrial
uncoupling in WAT is an increase of the AMP/ATP ratio
and activation of AMP kinase to 1) promote ATP-generat-
ing processes such as FA and glucose oxidation ([38,39]
and references therein) and 2) inhibit ATP-consuming
pathways such as lipogenesis, triglyceride synthesis and to
some extent lipolysis (36,38,40,41). Another outcome of
uncoupling in WAT could be protection against mitochon-
drial-derived reactive oxygen species and oxidative stress
directly within the adipocyte, which can lead to cellular
damage (12,36,42). Interestingly, we observed that adipo-
cytes derived from obese donors had a signiﬁcantly lower
OCR response to AR activation. In adipose tissue from
obese individuals, there is evidence for an impaired lipo-
lytic response in vivo and a reduced mitochondrial mass
(10,43), with a variety of mechanisms proposed (rev. in
26,27). Although we did not observe a difference in lipol-
ysis, our results suggest that there is a difference in the
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samples; each was measured in three different experiments, containing six to eight replicates. *P < 0.001, compared with lean.
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jects to increase respiratory activity in response to AR
stimulation, mirroring notions that an impaired response
of WAT to catecholamines at some level could be signiﬁ-
cant in the development or maintenance of obesity (27).
The ability of FAs to uncouple mitochondrial respiration
has been extensively investigated, particularly in tissues
such as BAT, muscle, and liver because of their high
aerobic capacity. The molecular basis mediating FA-in-
duced uncoupling has been vigorously discussed, and a
number of mitochondrial carriers have been suggested
(2,28,44,45). In BAT, the general consensus is that FAs
allosterically activate the “carrier” or “channel” properties
of UCP1 (46) (mechanistically still debated in some cir-
cles). By comparison, in WAT UCP1 levels are fairly
negligible whereas the UCP1 homologue, UCP2, is abun-
dant (47). UCP2 has periodically been proposed to medi-
ate proton leak or mitochondrial uncoupling ([1] and
references therein), but this point is not fully agreed upon
(48,49). However, regarding UCP2 there was no difference
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Ucp2-null mice. Moreover, the contribution of ANT2,
ANT3, PiC, and VDAC1 was excluded. Instead, a signiﬁ-
cant portion of AR and cAMP-induced OCR was inhibited
by the speciﬁc PTP inhibitor, CSA, as well as by suppress-
ing BAX expression—altogether suggesting that the open-
ing of the mitochondrial PTP by the regulatory protein
BAX is important for the observed mitochondrial uncou-
pling in WAT. Given that the amplitude of the OCR and
uncoupling response in the obese subjects was reduced,
we measured whether there was a change in expression of
BAX and the PTP in obese WAT. In our sample set, no
differences were detected in the expression levels of BAX
(or VDAC1 or ANTs) between lean and obese WAT.
However, proteins of the BCL-2 family are known to be
post-translationally modiﬁed, which controls their activity
and regulates PTP opening (30,50). Such modiﬁcations in
WAT mitochondria could reasonably be a basis for the
observed differences in mitochondrial function between
lean and obese, but will require further study and must be
extended to a larger sample set.
Because white adipocytes comprise the bulk of adipose
tissue in the body, even a moderate, sustained ability of
adipocytes to oxidize FAs could have several positive
consequences. First, limiting the amount of FAs released
into the circulation (13,24,37) would be protective against
lipotoxicity in other tissues, and second, it might contrib-
ute to whole body energy expenditure. The concept of
mitochondrial uncoupling as a strategy to reduce body
weight has been clearly demonstrated with the past clini-
cal use of such strong global uncouplers as 2,4-dinitrophe-
nol, but that enterprise was not without major side effects,
including fatalities (rev. in 48). Therefore, greater under-
standing of the mechanism(s) responsible for this cAMP-
dependent uncoupling in WAT and the role of the PTP is
warranted. The potential to identify novel agents and/or
processes that could be harnessed for selectively stimu-
lating moderate uncoupling are needed to combat the
metabolic disease epidemic.
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